Endocrine-related adverse events associated with immune-checkpoint inhibitors in patients with melanoma.
Kassi E, Angelousi A, Asonitis N, Diamantopoulos P, Anastasopoulou A, Papaxoinis G, Kokkinos M, Giovanopoulos I, Kyriakakis G, Petychaki F, Savelli A, Benopoulou O, Gogas H.
Kassi E, et al. Among authors: gogas h.
Cancer Med. 2019 Nov;8(15):6585-6594. doi: 10.1002/cam4.2533. Epub 2019 Sep 13.
Cancer Med. 2019.
PMID: 31518074
Free PMC article.